TransCode Therapeutics amends MGH license; milestone payments doubled to $2.95M per patent family

Transcode Therapeutics, Inc.

Second Amendment to Exclusive Patent License Agreement with Massachusetts General Hospital, effective August 15, 2025.
Updated timelines for pre-sales requirements for Patent Family 1 and Patent Family 2.
Aggregate one-time milestone payments increased from $1.55M to $2.95M for each patent family.
Individual milestone amounts for therapeutic product/process milestones also updated.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.